See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Social Media
Soccer
Donald Trump
World Cup
WWE
Artificial Intelligence
Floods
Immigration
Natural Disasters
Bitcoin
Tennis
Military
Interventional News image

News from Interventional News

Information about Interventional News

Where is Interventional News located?Interventional News's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Interventional News News

Why Is Merit Medical Stock Trading Higher On Tuesday? - Merit Medical Systems (NASDAQ:MMSI)
Health Care

Why Is Merit Medical Stock Trading Higher On Tuesday? - Merit Medical Systems (NASDAQ:MMSI)

60% Center coverage: 5 sources
Merit Medical Systems Inc. (NASDAQ:MMSI) announced a leadership transition on Monday, naming Martha Aronson as its next President and CEO, effective October 3, 2025. Current CEO Fred Lampropoulos, who founded the company in 1987, will continue to serve as Chairman of the Board following the transition. The Utah-based medical technology company also provided early revenue estimates for the second quarter, projecting between $380 million and $384 …See the Story
Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials
Amsterdam, Netherlands · Amsterdam

Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials

Coverage: 2 sources
VANCOUVER, BC / ACCESS Newswire / July 4, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into an agreement with Nucro-Technics Inc. ("Nucro-Technics"), dated July 3, 2025, pursuant to…See the Story
EmpNia Earns FDA Clearance for Respiratory Device
United States · United States

EmpNia Earns FDA Clearance for Respiratory Device

Minneapolis-based medical device innovator EmpNia has been granted clearance by the Food and Drug Administration (FDA) to market its wearable sensor, eMotus, to hospitals and cancer centers across the U.S. The company’s eMotus system is designed to help manage image-guided radiation therapy—specifically, for cancer patients. EmpNia’s team of medical professionals saw an opportunity to improve upon existing solutions, which they said can be hard …See the Story

Mendaera receives FDA 510(k) clearance for robotic system for ultrasound-guided needle placement - Interventional News

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Mendaera’s Focalist, a handheld robotic system designed to improve the precision of ultrasound-guided needle placement. According to the company in a recent press release, the system combines real-time imaging with a handheld robotic control to assist clinicians in performing a wide range of minimally invasive procedures and settings. Its features include robotic needle p…United States · United StatesRead Article

StentIt launches first-in-human trial of bioresorbable stent to treat below-the-knee CLTI - Interventional News

StentIt has announced the successful implantation of its Resorbable Fibrillated Scaffold (RFS). As part of the VITAL-IT 1 study, patients with chronic limb-threatening ischaemia (CLTI) below the knee have successfully been treated using the RFS implant. In this clinical procedure, revascularisation was achieved using an endovascular approach to restore blood flow to the foot. StentIt’s RFS device is a bioresorbable stent built from microfibers, …Graz · GrazRead Article

Medtronic Recall After 33 Injuries; Private Equity in Gastroenterology; MASLD Crisis

100% Center coverage: 3 sources
(MedPage Today) -- The FDA announced a recall of certain Medtronic Bravo esophageal pH monitoring capsules, which help in diagnosing gastroesophageal reflux, following 33 reports of serious injuries. Despite no-cost provisions in the Affordable...Health · United StatesSee the Story

Embolization Has Received FDA 510(k) Clearance for Its NED Embolization Device - Interventional News

Embolization has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA). The Nitinol Enhanced Device (NED) is a vascular embolization device intended for arterial and venous embolization in peripheral vasculature.  Vascular embolization is a minimally invasive procedure where a physician intentionally blocks a blood vessel using tiny materials such as coils, particles or glue. This stops bleeding, reduces …United States · United StatesSee the Story

Vivasure Submits PMA For Vascular Closure System To FDA - Data Intelligence

The system is a fully absorbable, sutureless closure device for use after percutaneous cardiovascular procedures. Credit: Max Acronym / Shutterstock. Irish company Vivasure Medical has submitted an application seeking premarket approval (PMA) from the US Food and Drug Administration (FDA) for its PerQseal Elite vascular closure system intended for arterial procedures. This submission is supported by the outcomes of the PATCH study and the system…FDA · United StatesSee the Story

E2 concludes enrolment of pulmonary embolism thrombectomy system trial

100% Center coverage: 1 sources
E2 has completed enrolment of subjects in the pivotal cohort of its ENGULF trial, involving the Hēlo PE Thrombectomy System.The post E2 concludes enrolment of pulmonary embolism thrombectomy system trial appeared first on Medical Device Network.See the Story

Gore Tag thoracic branch endoprosthesis receives expanded FDA approval for endovascular aortic arch repair - Interventional News

Gore Tag Gore has announced that the Gore Tag thoracic branch endoprosthesis (TBE) is now approved by the US Food and Drug Administration (FDA) for use in Zones 0 and 1, expanding its indication for the endovascular repair of lesions in the aortic arch and descending thoracic aorta while preserving flow to a single aortic arch branch vessel. The device becomes the first off-the-shelf, single-branch thoracic endoprosthesis indicated across Zones …United States · United StatesRead Article

First Patient Enrolled in RECOVER-AV Trial of AlphaVac F18 System for Treatment of Acute PE - Cardiovascular News

AngioDynamics has announced the first patient has been enrolled in the RECOVER-AV clinical trial, a prospective, multicentre, international, single-arm study evaluating the AlphaVac multipurpose mechanical aspiration (MMA) F1885 system in the treatment of acute, intermediate-risk pulmonary embolism (PE). The study follows the US Food and Drug Administration (FDA) 510(k) clearance of the AlphaVac F1885 system for the treatment of PE in the USA in…Canada · CanadaSee the Story

Breaking News Topics Related to Interventional News

New York State icon

New York State

England icon

England

United States icon

United States

Melbourne, Australia icon

Melbourne, Australia

United Kingdom icon

United Kingdom

News
For You
SearchBlindspotLocal